Deep-tech startups work on technologies that need serious research, advanced engineering and long periods of testing before a product can reach the market. Quantum computing, robotics, space systems, biotechnology, advanced materials, semiconductors, medical devices and AI hardware all fit this model. These companies can create very large businesses, but their path from an idea to a commercial product rarely looks like the path of a software startup.
A typical software company can build a product, find early customers and show revenue within a relatively short period. A deep-tech company may need years before a customer can buy the final product. The company may first need to prove that the science works, then build a prototype, complete tests, meet safety or industry standards, run pilots and finally create a production system.
That difference changes the funding problem. A founder cannot simply raise a seed round, then a Series A and Series B, while using revenue growth as the main proof of progress. Deep tech needs capital at several different points, and each point has a different risk profile.
The latest global data shows why this matters. Deep tech took 32% of all European venture capital funding in 2025, more than double its 15% share in 2015. In the United States, deep-tech funding reached about $141 billion in 2025, almost twice the $69.6 billion raised in 2024 and about nine times Europe’s $15.5 billion.
The larger funding pool looks encouraging, but the distribution of capital tells a more complex story.
The real problem comes after the first round
Early funding can help a research-heavy startup build its first prototype. The harder problem often comes later.
The US-Europe data gives a clear example. The funding gap between the two markets stands at about 2x at early stages, but it rises to as much as 16x at later stages. Europe can produce deep-tech startups, but many companies still face difficulty when they need much larger amounts of capital for commercial scale.
This matters for deep-tech founders more than for many software founders. A software business can sometimes grow without large physical assets. A company that makes a satellite, medical device, semiconductor, battery system or industrial robot needs laboratories, specialist equipment, production capacity, testing facilities and highly skilled technical teams.
Those costs arrive before the company can show mature revenue.
That creates what can be called a commercialisation gap. The technology may already work at a small scale, yet the company may still sit years away from dependable commercial revenue. Traditional investors may see too much technical risk for a normal growth investment, while specialist investors may see a strong opportunity but require more proof before committing large sums.
This gap explains why deep-tech companies need a wider funding strategy.
Research capital should not carry the entire company
One of the biggest mistakes in deep tech comes from treating every rupee or dollar as the same type of capital.
Early research should use capital that can tolerate high technical risk. Grants, research support, university partnerships and public programmes can play an important role at this stage. Venture capital can then enter at a point where the technology has stronger evidence.
The logic is simple. Equity becomes more valuable when a company has fewer unknowns.
A founder who raises a large equity round before technical validation may give away a substantial part of the company at a low valuation. A founder who uses research support to reach a major technical milestone can potentially approach later investors with stronger evidence and a better valuation case.
That does not mean grants can replace venture capital. Deep-tech businesses still need private money for teams, product development, sales, manufacturing and international expansion. The better strategy combines different sources rather than forcing one investor type to fund every stage.
India is creating a new funding layer
India’s deep-tech funding landscape has received a major boost from the ₹1 lakh crore Research, Development and Innovation Fund.
The Union Cabinet approved the RDI Scheme in July 2025, and the programme launched in November 2025. The scheme has a total corpus of ₹1 lakh crore over six years, with ₹20,000 crore allocated for FY 2025–26. Its focus includes high-risk and high-impact research, private-sector innovation and the commercialisation of indigenous technologies.
The structure itself shows why deep tech needs a different financing model.
The RDI Fund can provide long-term, low-interest loans, equity support for startups and contributions to deep-tech funds of funds. The scheme can finance up to 50% of an assessed project cost, while the remaining amount must come from the company itself or commercial sources.
This structure does something important. It brings public capital alongside private capital rather than trying to replace private investment.
The government has also set the programme around technologies with strategic importance. Priority areas include quantum computing, robotics, space, artificial intelligence, biotechnology, biomanufacturing, synthetic biology, pharmaceuticals, medical devices, energy security, climate technology and the digital economy.
The RDI Fund has moved from policy to execution
The programme has now moved beyond an announcement.
By July 2026, the Technology Development Board had approved 22 projects with a total project cost of ₹4,744 crore, with ₹2,192 crore of RDI support. BIRAC had also shortlisted eight projects worth ₹390.35 crore for support. The government had sanctioned ₹1,000 crore each to TDB and BIRAC as Second Level Fund Managers.
The government had also received 162 applications from Alternative Investment Funds and 38 applications from Focused Research Organisations for the wider fund-management structure. The proposed commitments across those applications stood at around ₹8,000 crore.
This matters for founders and investors alike. The Indian deep-tech funding market is slowly moving from a model based mainly on venture capital toward a blended system with government finance, specialist funds, institutional capital and strategic investors.
Milestones matter more than time
Traditional startup finance often uses time as a rough measure of progress. A company may raise enough money for 18 or 24 months and then return to the market.
Deep tech needs a different clock.
A better question is whether the company has reached a major technical or commercial milestone.
For a robotics company, that milestone could mean successful operation in a real factory. For a space startup, it could mean a successful launch or an important satellite test. For a medical-device company, it could mean regulatory progress. For a semiconductor startup, it could mean a successful tape-out, fabrication result or customer qualification.
Capital should match these milestones.
The RDI model reflects this idea. The first five startups selected under the fund include e-TRNL Energy, Dhruva Space, Eyestem Research, Noccarc Robotics and EndureAir Systems, with work across batteries, space, healthcare, robotics and biotechnology. The first cohort uses milestone-based financing, with money tied to agreed technical and financial targets.
That approach fits deep tech far better than a simple promise of future revenue growth.
Strategic investors can matter as much as venture capital
A deep-tech startup may need more than money.
A semiconductor company may need access to fabrication capacity. A space startup may need launch partners. A medical-device company may need hospital access and regulatory expertise. An industrial robotics company may need a large manufacturer willing to run a pilot.
This makes strategic investors especially important.
A corporate investor can bring customers, technical knowledge, production access and distribution channels along with capital. Such support can reduce the time between a successful prototype and a commercial product.
This model already has relevance in India’s industrial technology market. Large companies are forming partnerships with deep-tech firms to bring AI, automation and advanced technologies into industrial operations. Such relationships can give startups a path from laboratory work to real commercial use.
The ideal strategic investor therefore should not be selected only for the size of the cheque. Its industrial position can matter just as much.
Manufacturing creates another funding problem
A deep-tech company can prove its technology and still face a large financial challenge.
A working prototype does not equal a factory.
Commercial production can require new machines, specialist facilities, supply-chain contracts, quality systems and working capital. A startup that uses only equity for all these needs can suffer heavy dilution.
That makes debt, equipment finance, project finance and strategic capital more relevant once technical risk falls.
The funding strategy should therefore change as the company matures. Early equity can support research and product development. Later capital can support manufacturing and commercial deployment. Once the business has predictable contracts and cash flows, debt can become more useful.
The goal is not to avoid equity. The goal is to use equity where it creates the most value.
India has a particular scale-up opportunity
India’s deep-tech market now sits at an interesting point.
The country has a large engineering and scientific talent base, a growing startup ecosystem and stronger government support for strategic technologies. The RDI Fund adds a major new source of long-term capital. At the same time, the market still needs more specialist investors who understand technologies that may take many years to mature.
The semiconductor sector shows both sides of this story. India has attracted a sharp rise in semiconductor capital, but recent data also shows that much of that money has gone to a relatively small group of companies. That concentration highlights the need for broader capital access across the ecosystem.
The challenge now is not only to create more deep-tech startups. It is to help promising companies cross the difficult distance between technical proof and large-scale commercial production.
The funding strategy must change with the company
A strong deep-tech company should not approach every funding round with the same plan.
At the research stage, the priority should remain technical proof. Public research support, grants, university partnerships and early specialist investors can carry much of this work.
At the prototype stage, specialist venture capital becomes more important. The company needs enough money to build a reliable product and produce evidence from real tests.
At the pilot stage, corporate partners and strategic investors can add major value. Customer contracts can also provide a stronger signal than another round of theoretical investor interest.
At the manufacturing stage, the capital mix should widen. Growth equity, long-term loans, equipment finance and project capital can reduce the pressure on the company’s equity base.
At global scale, larger growth funds, private equity, strategic corporations and public markets can become relevant.
This creates a simple principle: the right capital should match the risk at each stage.
Deep tech needs patient capital, not endless capital
The answer is not simply to give deep-tech startups more money.
The better answer is to give them the right money at the right time.
A company that still faces major scientific uncertainty needs patient risk capital. A company with proven technology but expensive production needs scale capital. A company with strong contracts and predictable cash flow can use debt more effectively.
Europe’s experience shows the value of a connected funding system. The European Innovation Council reports €15.5 billion raised by EIC-backed companies, with €6.5 billion invested through the EIC and €5 billion mobilised in private co-investment. The EIC says its funding has leveraged about €3.5 for every €1 invested, with more than 1,000 co-investors involved.
That is the direction the wider deep-tech market needs.
The next phase will reward better capital design
Deep tech has moved well beyond a niche investment theme. In 2025, it represented 32% of European VC funding, while US deep-tech funding reached more than $140 billion. At the same time, the large later-stage funding gap shows that early success does not automatically translate into commercial scale.
India now has an opportunity to build a funding system around that reality. The ₹1 lakh crore RDI Fund, its long-term financing structure and its support for deep-tech funds can create a stronger bridge between research and commercial markets.
The winning model will not rely on venture capital alone. It will combine public finance, specialist venture funds, strategic corporate investment, customer contracts, long-term debt and growth capital.
For deep-tech founders, that shift can change the entire economics of building a company. Instead of using expensive equity for every stage, each milestone can receive capital suited to its risk. Instead of raising money simply to survive another year, funding can support a clear technical or commercial breakthrough.
That is why deep-tech startups need different funding strategies. Their technologies take longer, their assets cost more, their risks change sharply across stages and their biggest value creation often comes before revenue reaches its full scale. A funding strategy that understands those realities can give promising technologies a far better chance to become durable companies.
Also Read – How AI Agents Transform Startup Sales: Essential First Automations